The researchers sought to determine the clinical and biochemical features of alemtuzumab-induced autoimmune thyroid events and look their risk factors with a focus on fluctuating Graves’ disease.
Vitamin D deficiency has been diagnosed in an estimated 1 billion people worldwide. An essential fat-soluble nutrient with hormone like-activity, researchers sought to discover whether there was a link between low vitamin D levels and thyroid disorders.
Researchers examined the relationship of radiaoactive iodine treatment on antithyroid antibody levels and a potential link between these levels and radioiodine uptake in people with Graves disease.
Investigators assessed the relationship between intraoperative measurements obtained via laser speckle contrast imaging and outcomes following total thyroidectomy.
Graves disease and other thyroid-related diseases of the eyes may benefit from teprotumumab therapy, according to a multicenter, multinational study.
The objective of the study was to estimate the shared genetic influence on overt Hashimoto thyroiditis and Graves disease and to examine if the heritability for them differs between men and women.
Several factors may predict normal thyroid function after radioiodine therapy for hyperthyroidism, including older age and larger volume of thyroid gland.
Researchers identified predictors of biochemical treatment response to antithyroid drugs, specifically methimazole, in patients with Graves disease.
The American Association of Endocrine Surgeons has published the first comprehensive guidelines for safe, effective, and appropriate thyroidectomy.
In most cases of overt hyperthyroidism, patients present with a constellation of symptoms, and appropriate treatment depends on the underlying mechanism.
